Roche snaps up Marcadia Biotech

Roche ended 2010 much as it began the year--snapping up biotech developers and their products. The pharma giant reported that it bought Indiana-based Marcadia Biotech, a tiny company which has been working on new treatments for obesity and diabetes. Marcadia was founded by a pair of Eli Lilly veterans, Richard DiMarchi and Gus Watanabe, who died in 2009. 5AM Investors, Frazier Healthcare Ventures and Twilight Venture Partners provided $15 million in venture funds back in 2007. Roche didn't offer any details on the buyout, saying that would come later. Report

Suggested Articles

Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.

The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy.

The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.